Status: current, Defined. Date: 30-Nov 2019. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4262491000168110 | Irinotecan (WKT) (irinotecan hydrochloride trihydrate 40 mg / 2 mL) injection, 1 x 2 mL vial (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4262501000168115 | Irinotecan (WKT) 40 mg/2 mL injection, 2 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Irinotecan (WKT) 40 mg/2 mL injection, 2 mL vial | Is a | irinotecan hydrochloride trihydrate 40 mg/2 mL injection, 2 mL vial | true | Inferred relationship | Some | ||
Irinotecan (WKT) 40 mg/2 mL injection, 2 mL vial | Is a | trade product pack | true | Inferred relationship | Some | ||
Irinotecan (WKT) 40 mg/2 mL injection, 2 mL vial | has TP | Irinotecan (WKT) | true | Inferred relationship | Some | ||
Irinotecan (WKT) 40 mg/2 mL injection, 2 mL vial | has TPUU | Irinotecan (WKT) 40 mg/2 mL injection, 2 mL vial | true | Inferred relationship | Some | 2024366479 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Irinotecan (WKT) 40 mg/2 mL injection, 2 mL vial | Is a | True | Irinotecan (WKT) 40 mg/2 mL injection, 2 mL vial | Inferred relationship | Some |
Reference Sets
Trade product pack reference set